Frontlight ResearchEarly access
CompletedNo phase
Cataract Monitored Anesthesia Care (MAC) Feasibility Pilot Study
Key facts
- Who runs it
- University of California, San Francisco
- Where
- San Francisco, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 23 people enrolled
- Started
- 12 Jun 2024
- Ended
- 29 May 2025
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Oral sedation
- Placebo
- Record updated
- 9 July 2026
Who can take part
- Age
- 60 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 23 criteriaShow less
Who can take part
- ≥ 60 years old
- Capable of providing informed consent and completing the study procedures in English
- Able to provide consent for oneself
- Able to follow directions
- Able to climb one flight of stairs without stopping to rest
- Have a new diagnosis of cataract disease
- Plan on having cataract surgery on their eye within the next 6 months
Who cannot take part
- History of prior cataract surgery
- Patient undergoing cataract surgery in combination with any other ophthalmologic procedure
- Patient requiring general anesthesia during cataract surgery due to the underlying characteristics of the existing cataract and/or anticipated complexity of the planned procedure
- Allergy or resistance to local anesthetic agents
- History of severe anxiety requiring routine use of benzodiazepines
- Severe valve disease (e.g., critical aortic stenosis)
- Cardiac conditions requiring an implanted cardiac device such as a pacemaker, defibrillator, or left ventricular assist device (for arrhythmia, congestive heart failure, etc.)
- Untreated chest pain or angina
- Patients with movement disorders (e.g., Parkinson's Disease)
- History of Cerebral Vascular Accident (CVA), Transient Ischemic Attack (TIA), or seizures
- End-stage renal disease (ESRD) requiring dialysis
- Admission to the hospital within the past 30 days
- Difficulty being sedated during other minor outpatient procedures or imaging studies
- Cannot lay flat on your back without having symptoms (i.e., difficulty breathing, severe back pain, etc.)
- Require home oxygen (O2) at rest or with exertion
- Morbid obesity (BMI>35)
Where in United States
- University of California San FranciscoSan Francisco, United States
About the trial
What the trial wants to find out
The goal of this pilot clinical trial comparing two different sedation approaches for cataract surgery is to assess the feasibility, completeness, and distribution of data in measuring patient satisfaction, the quality of recovery, and surgical outcomes for the purpose of planning a larger clinical trial. Participants will be asked to respond to several surveys throughout the study on their experience and to assess outcomes of interest.
The 2 groups in the trial
- InterventionTreatment being tested
Oral sedation will be administered to patients prior to the procedure.
Treatment: Oral sedation
- PlaceboPlacebo, for comparison
An oral placebo pill will be administered to patients prior to the procedure.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparing Two Normal Approaches to Procedural Sedation for Cataract Surgery: A Prospective, Feasibility Pilot Study
- Record updated
- 9 July 2026